Figure 1 Comparison of tumor size at time of excision between axillary node-negative, axillary node-positive, and distant metastasis subgroups of basal-like.

Slides:

Advertisements

Similar presentations

Triple-Negative Breast Cancer

Advertisements

Is mammacarcinoom onder de veertig jaar morfologisch en genetisch een andere ziekte? Marc van de Vijver, Netherlands Cancer Institute, Amsterdam, NL.

The origin of metastatic disease: clues from genomics 7/13/2011.

 - an important step in surgical staging for uterine cancer (FIGO 1988)  Stated as 

Geonomics in Breast Cancer Decoding Human Genome Luis Barreras, M.D., FACP.

Breast Cancers With Brain Metastases are More Likely to be Estrogen Receptor Negative, Express the Basal Cytokeratin CK5/6, and Overexpress HER2 or EGFR.

NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.

ANNUAL SLIDE SEMINAR June Bratislava Slovakia B. Fredrik Petersson MD, PhD Department of Pathology, Karolinska University Hospital Stockholm.

Ductal Carcinoma in Situ with Microinvasion: Prognostic Implications, Long-term Outcomes, and Role of Axillary Evaluation Rahul R. Parikh, MD 1, Bruce.

Breast Cancer 1. Leukemia & Lymphoma New diagnoses each year in the US: 112, 610 Adults 5,720 Children 43,340 died of leukemia or lymphoma in

Staging System and Excision Types Tae Won Kim, MD PCOM Tumor Review

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.

Invasive skin carcinoma—Ras and α6β4 integrin lead the way

Number of brain metastasis

Figure 1. Correlation between estrogen receptor (ER), progesterone receptor (PR), and Ki-67 expression in primary breast tumors and synchronous axillary.

Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer Victor E. Chen, BS, Erin.

Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB (HER2-Positive) and CALGB.

Fig. 2. Kaplan-Meier curves for survival in each breast cancer molecular subtype. Radiologic assessment in triple-negative breast cancer (A), HER2-positive.

Image 1 Melanocytes in control anorectal mucosa (hemorrhoids) highlighted by MITF ( A ) and HMB45 ( B ) immunostains as single, scattered, and basally.

Underwriting Breast Cancer

TUMOR PD-L1 TIL PD-L1 TUMOR & TIL PD-L1 Age Low High P value R Pearson

Figure 2. DNA methylation mediated MORT gene silencing is linked to luminal, receptor positive breast cancers. (A) MORT expression level plotted versus.

Image 3 Cytomorphologic criteria for circulating nonhematologic cells with benign features obtained by the isolation by size of epithelial tumor cell method.

Ductal Carcinoma In Situ With Microinvasion: Prognostic Implications, Long-Term Outcomes, and Role of Axillary Evaluation Rahul R. Parikh, M.D., Bruce.

Reproduced with permission from Cronin M et al

From: Overexpression of the μ-Opioid Receptor in Human Non-Small Cell Lung Cancer Promotes Akt and mTOR Activation, Tumor Growth, and Metastasis Anesthes.

VEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast Cancer Reija Valtola, Petri Salven, Päivi Heikkilä, Jussi Taipale, Heikki Joensuu,

Canine invasive mammary carcinoma as a spontaneous model

From: Platelet Factor 4/Heparin Antibodies in Blood Bank Donors

Table (1):Relation between lymph node and molecular subtypes.

Figure 1. MORT gene silencing is early event in cancer

Image 1 Detection of minimal residual disease (MRD) in consecutive bone marrow (BM) samples from a patient with relapse (A) and a patient still in remission.

Figure 2 Percentage of CD19+/CD34+ cells with decreased CD81 median fluorescence intensity (MFI;

Triple-Negative Breast Cancer

徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2

Dr T P E Wells 13 July 2018 Breast SSG Bath

Identification and Characterization of Optimal Gene Expression Markers for Detection of Breast Cancer Metastasis John Backus, Todd Laughlin, Yixin Wang,

A Long Noncoding RNA Signature That Predicts Pathological Complete Remission Rate Sensitively in Neoadjuvant Treatment of Breast Cancer Gen Wang, Xiaosong.

Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas Yiliang Zhang, MD, Rui Wang, MD, PhD, Yuan.

Sarcoma Wound Complications

Bronchioloalveolar Carcinoma (Lepidic Growth) Component Is a More Useful Prognostic Factor than Lymph Node Metastasis Yoichi Anami, MD, Tatsuo Iijima,

Association of Epidermal Growth Factor Receptor Activating Mutations with Low ERCC1 Gene Expression in Non-small Cell Lung Cancer David R. Gandara, MD,

Human epidermal growth factor receptor 2 borderline mortality in breast cancer patients: Evidence from surveillance, epidemiology, and end results program.

Diagnostic and Prognostic Value of Metastasis Inducer S100A4 Transcripts in Plasma of Colon, Rectal, and Gastric Cancer Patients Ulrike Stein, Susen.

Vp and Ktrans parameters obtained for atypical hemangiomas and metastatic lesions from breast and lung carcinoma. Vp and Ktrans parameters obtained for.

Fig. 1 Localized treatment of TNBC cancers kills tumor cells and minimizes the metastatic burden. Localized treatment of TNBC cancers kills tumor cells.

Lipid Metabolism Fuels Cancer’s Spread

Katja Lundgren, Nicholas P

Disease-specific survival

Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: A single- institution experience Bin Li, MD, Haiquan Chen, MD, Jiaqing Xiang,

PET Scanning in Thymic Neuroendocrine Tumors

Distribution of intrinsic subtypes among TNBC and distribution of TNBC among basal-like breast cancer. Distribution of intrinsic subtypes among TNBC and.

Histological and molecular heterogeneity of triple negative breast cancer (TNBC). Histological and molecular heterogeneity of triple negative breast cancer (TNBC).

Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors Benny Weksler, MD, Anthony Holden, MD, Jennifer.

Clinical courses of patients.

Detection rate of EGFR mutations in cfDNA by characteristics

Erratum Journal of Thoracic Oncology

Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases Paul C. Lee, MD, Jeffrey L. Port, MD, Subroto.

Intratumoral Heterogeneity of MicroRNA Expression in Breast Cancer

FMRP is highly expressed in human breast cancer and distal metastasis FMRP expression on human TMAs containing normal and multi‐tumour tissues. FMRP is.

Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki,

Heterogeneity in the natural history of triple negative breast cancer.

MRNA expression IL-1α, IL-1β, IL-1Ra, IL-1RtI, ER α, ER β, and PR was analyzed by RT-PCR as described in “Materials and Methods.” Representative gel electrographies.

Serial imaging before and after immunotherapy among patients with MDM2/4 amplifications (N = 6). Serial imaging before and after immunotherapy among patients.

Gamma camera images at 72 h of patient with T4N2M1 ductal breast cancer (patient 6). Gamma camera images at 72 h of patient with T4N2M1 ductal breast cancer.

Example inverse FF-OCT images (left column) and corresponding histology images (right column) of ovarian metastases. Example inverse FF-OCT images (left.

Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer An imaging-based predictive model.

Invasive skin carcinoma—Ras and α6β4 integrin lead the way

Human epidermal growth factor receptor 2 borderline mortality in breast cancer patients: Evidence from surveillance, epidemiology, and end results program.

Detection of E-cadherin fragments in human prostate cancer metastases.

Presentation transcript:

Figure 1 Comparison of tumor size at time of excision between axillary node-negative, axillary node-positive, and distant metastasis subgroups of basal-like triple-negative tumors. From: Intratumoral Expression Level of Epidermal Growth Factor Receptor and Cytokeratin 5/6 Is Significantly Associated With Nodal and Distant Metastases in Patients With Basal-like Triple-Negative Breast Carcinoma Am J Clin Pathol. 2015;134(5):782-787. doi:10.1309/AJCPRMD3ARUO5WPN Am J Clin Pathol | © American Society for Clinical Pathology 1